Canada markets open in 1 hour 6 minutes

InMed Pharmaceuticals Inc. (INM)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.2520-0.0510 (-16.83%)
At close: 04:00PM EDT
0.2496 -0.00 (-1.34%)
Pre-Market: 08:22AM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.53M
Enterprise Value -6.84M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.21
Price/Book (mrq)0.12
Enterprise Value/Revenue -1.25
Enterprise Value/EBITDA 1.07

Trading Information

Stock Price History

Beta (5Y Monthly) 0.48
52-Week Change 3-79.00%
S&P500 52-Week Change 321.08%
52 Week High 32.0800
52 Week Low 30.2500
50-Day Moving Average 30.3529
200-Day Moving Average 30.5546

Share Statistics

Avg Vol (3 month) 3376.21k
Avg Vol (10 day) 3595.12k
Shares Outstanding 56.06M
Implied Shares Outstanding 66.06M
Float 84.84M
% Held by Insiders 11.36%
% Held by Institutions 113.29%
Shares Short (Apr 15, 2024) 4114.49k
Short Ratio (Apr 15, 2024) 40.24
Short % of Float (Apr 15, 2024) 41.89%
Short % of Shares Outstanding (Apr 15, 2024) 41.89%
Shares Short (prior month Mar 15, 2024) 456.97k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul 06, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:25
Last Split Date 3Sept 07, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -115.75%
Operating Margin (ttm)-137.47%

Management Effectiveness

Return on Assets (ttm)-27.17%
Return on Equity (ttm)-46.86%

Income Statement

Revenue (ttm)5.49M
Revenue Per Share (ttm)1.22
Quarterly Revenue Growth (yoy)164.00%
Gross Profit (ttm)N/A
EBITDA -6.78M
Net Income Avi to Common (ttm)-6.35M
Diluted EPS (ttm)-0.4200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.58M
Total Cash Per Share (mrq)1.58
Total Debt (mrq)1.17M
Total Debt/Equity (mrq)9.14%
Current Ratio (mrq)7.03
Book Value Per Share (mrq)2.25

Cash Flow Statement

Operating Cash Flow (ttm)-6.34M
Levered Free Cash Flow (ttm)-4.19M